Publication Archive: Opioids Litigation

Members of the Sackler family, owner of OxyContin maker Purdue Pharma, are living near Boca Raton in a sprawling mansion bought for $7.4 million. The purchase is the second real estate investment by the Sacklers in Palm Beach County, a ground zero in the nationwide opioid crisis. The property purchases in Palm Beach County, the…Read the article

Teva Pharmaceutical Industries Ltd’s proposed $23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review of pricing data and industry analysts. In interviews with Reuters, lawyers representing local governments in the…Read the article

Following a major settlement in Ohio this week, California counties could be a step closer to getting the drug industry to pay for damages associated with the opioid epidemic. The nation’s three biggest drug distributors and a major drugmaker reached an 11th-hour, $260 million settlement over the toll of the opioids in two Ohio counties,…Read the article

Lead lawyer for Cuyahoga County Hunter J. Shkolnik, partner at Napoli Shkolnik of New York City, said the funds from the case will be used entirely for treatment. “What’s significant is we have brought to Cuyahoga County and my co-counsel with respect to Summit County money now, significant money now, and also it set a…Read the article

When Teva announced the value of the donated medicine, a generic version of opioid addiction treatment Suboxone, it based the figure on the drug’s list price, which does not account for significant discounts routinely provided by the drugmaker. If based on the estimated cost to manufacture the drugs, the value could be as low as…Read the article

In interviews with Reuters, lawyers representing local governments in the opioid litigation said the figure proposed by Teva inflates the real value of the drugs. They said the proposal will not be enough to address a nationwide addiction crisis that has claimed some 400,000 lives over the last two decades. The deal is “overvalued to…Read the article

J&J, Teva offer a massive $48B combined to wrap opioid suits, but not all plaintiffs are on board With reports like that in the ether, it’s no wonder some plaintiffs are reticent to sign on to the “framework deal” that includes the Teva and J&J offers, along with additional deals with three drug distributors. Officials in at least four…Read the article

In interviews with Reuters, lawyers representing local governments in the opioid litigation said the figure proposed by Teva inflates the real value of the drugs. They said the proposal will not be enough to address a nationwide addiction crisis that has claimed some 400,000 lives over the last two decades. The deal is “overvalued to…Read the article

While the nation’s first federal opioid trial ended Monday without an actual trial, the cases drug companies face nationwide are far from over. Attorneys representing the thousands cities and counties in federal court said they intend to pursue their other cases and that negotiations should continue. After talks broke down on Friday with state attorneys…Read the article

The deal settles claims brought by Ohio’s Cuya hoga and Summit counties, which had accused the companies of fuelling a nationwide opioid crisis. Some 400,000 US overdose deaths between 1997 and 2017 were linked to opioids, ac cording to government data. The trial was to be a so-called bellwether, or test trial, that was meant…Read the article